| Literature DB >> 33652827 |
Lei Li1, Haisheng He2, Sifang Jiang3, Jianping Qi2, Yi Lu2, Ning Ding4, Hai-Shu Lin5, Wei Wu2, Xiaoqiang Xiang1.
Abstract
The application of physiologically based pharmacokinetic models to nanoparticles is still very restricted and challenging, owing to the complicated in vivo transport mechanisms involving nanoparticles, including phagocytosis, enhanced permeability and retention effects, cellular recognition, and internalisation, enzymatic degradation, lymphatic transport, and changes in physical properties. In our study, five nanoparticle formulations were synthesised using polycaprolactone as a framework material and methoxy poly (ethylene glycol)-poly(ε-caprolactone) as a long-circulating decorating material, as well as types of environmentally responsive near-infrared aza-boron-dipyrromethene dyes. According to quantification data and direct visualisation involving specific organs, a phagocytosis physiologically based pharmacokinetic model was developed to describe the dynamics of nanoparticles within and between organs in mice, considering cellular mechanisms involving phagocytosis and enhanced permeability and retention effects. Our results offer a better understanding of the in vivo fate of polymeric nanoparticles.Entities:
Keywords: biodistribution; methoxy poly (ethylene glycol)-poly (ε-caprolactone); nanoparticles; phagocytosis; physiologically based pharmacokinetic model
Mesh:
Substances:
Year: 2021 PMID: 33652827 PMCID: PMC7956253 DOI: 10.3390/molecules26051271
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411